Author:
Onoue Masahide,Terada Tomohiro,Kobayashi Masahiko,Katsura Toshiya,Matsumoto Shigemi,Yanagihara Kazuhiro,Nishimura Takafumi,Kanai Masashi,Teramukai Satoshi,Shimizu Akira,Fukushima Masanori,Inui Ken-ichi
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Hematology,General Medicine,Surgery
Reference26 articles.
1. Meyerhardt JA, Mayer RJ (2005) Systemic therapy for colorectal cancer. N Engl J Med 352:476–487
2. Noda K, Nishiwaki Y, Kawahara M, et al. (2002) Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 346:85–91
3. Hahn KK, Wolff JJ, Kolesar JM (2006) Pharmacogenetics and irinotecan therapy. Am J Health Syst Pharm 63:2211–2217
4. Innocenti F, Undevia SD, Iyer L, et al. (2004) Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan. J Clin Oncol 22:1382–1388
5. Ando Y, Saka H, Ando M, et al. (2000) Polymorphisms of UDPglucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis. Cancer Res 60:6921–6926
Cited by
88 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献